Solicitation of Nominations for Appointment to CDC's Advisory Committee to the Director (ACD) Health Equity Workgroup (HEW), 12709-12710 [2022-04690]
Download as PDF
<![CDATA[
12709
Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices
may instead submit to CDC a signed
statement from a local health authority,
on the health authority’s official
letterhead, indicating that the health
authority has declined to participate in
deliberations and/or sign the port
agreement, i.e., a ‘‘Statement of NonParticipation.’’ The cruise ship operator
can submit to CDC documentation of
attempted communication with the
local health authority regarding the port
agreement if a response is not received
or if the local health authority declines
to provide a signed statement.
Additionally, the cruise ship operator
may enter into a multi-port agreement
(as opposed to a single port agreement)
provided that all relevant port and local
health authorities (including the state
health authorities) are signatories to the
agreement.
During discussions with cruise ship
operators, port authorities, and state and
local health authorities, all parties
requested CDC assistance with the
required agreements. In response to
these requests, CDC has created specific
guidance for additional reference.
Inspections
Cruise ships participating in CDC’s
program are subject to in-person
inspections by CDC inspectors. The
cruise ship operator’s properties and
records must be made available for
inspection to allow CDC to ascertain
compliance with its requirements. Such
properties and records include but are
not limited to vessels, facilities,
vehicles, equipment, communications,
manifests, list of passengers, laboratory
test results, and employee and
passenger health records. CDC has
issued additional technical guidance
outlining the specific areas that may be
inspected and corresponding
recommendations.
CDC has provided, and will continue
to provide as necessary, the technical
instructions for the COVID–19 Program
for Cruise Ships. CDC will work closely
with cruise industry, state, territorial,
and local health authorities, and seaport
partners to evaluate the program
components no later than March 18,
2022, and update them as needed. The
evaluation will include a review of all
public health recommendations and
guidance issued as part of the program
based on public health conditions and
available scientific evidence.
CDC requests OMB approval for an
estimated 17,532 annual burden hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Form or information collection name
Cruise ship brand/operator .............................
COVID–19 Program for Cruise Ships Notice
of Participation/Nonparticipation.
Cruise Ship Vaccination Status Classification
COVID–19 Response Plan ............................
Enhanced Data Collection (EDC) During
COVID–19 Pandemic Form (Daily).
Cruise COVID–19 Case Investigation Worksheet (if necessary).
Cruise COVID–19 Contact Investigation
Worksheet (if necessary).
Agreement with Health Care Organization
with signoff from Local Health Authorities.
Agreement with Port of Entry with signoff
from Local Health Authority.
Agreement with Housing Facility with signoff
from Local Health Authority.
Inspections .....................................................
Cruise ship brand/operator .............................
Cruise ship parent company ...........................
Cruise ship physician ......................................
Cruise ship physician ......................................
Cruise ship physician ......................................
Cruise ship brand/operator .............................
Cruise ship brand/operator .............................
Cruise ship brand/operator .............................
Cruise ship operator .......................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–04668 Filed 3–4–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to CDC’s Advisory
Committee to the Director (ACD)
Health Equity Workgroup (HEW)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
SUMMARY:
VerDate Sep<11>2014
17:50 Mar 04, 2022
Jkt 256001
Services (HHS), is seeking nominations
for membership on the Advisory
Committee to the Director (ACD) Health
Equity Workgroup (HEW). The HEW
will consist of approximately 15
members who are experts in fields
associated with health equity; public
health science and practice; public
health policy development, analysis,
and implementation.
DATES: Nominations for membership on
the HEW workgroup must be received
no later than March 17, 2022. Late
nominations will not be considered for
membership.
ADDRESSES: All nominations (cover
letters and curriculum vitae) should be
emailed to ACDirector@cdc.gov with the
subject line: ‘‘Nomination for CDC ACD
HEW Workgroup.’’
FOR FURTHER INFORMATION CONTACT:
Kerry Caudwell, MPA, Centers for
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Number of
respondents
Number
responses
per
respondent
Avg. burden
per response
(hours)
20
1
300/60
130
3
130
1
1
365
5/60
2,400/60
20/60
104
1
30/60
24
1
30/60
30
1
600/60
30
1
600/60
30
1
600/60
130
2
120/60
Disease Control and Prevention, Office
of the Chief of Staff, 1600 Clifton Road
NE, MS H21–10, Atlanta, Georgia
30329–4027, Telephone: (404) 639–
7000; Email Address: ACDirector@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The purpose of the ACD,
CDC is to advise the Secretary, HHS,
and the Director, CDC, on policy and
broad strategies that will enable CDC to
fulfill its mission of protecting health
through health promotion, prevention,
and preparedness. The ACD, CDC
consists of up to 15 non-federal
members, including the Chair,
knowledgeable in areas pertinent to the
CDC mission, such as health policy,
public health, global health,
preparedness, preventive medicine, the
faith-based and community-based
sector, and allied fields.
E:\FR\FM\07MRN1.SGM
07MRN1
khammond on DSKJM1Z7X2PROD with NOTICES
12710
Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices
Purpose: The establishment and
formation of the HEW is to provide
input to the ACD, CDC on agency-wide
activities related to the scope and
implementation of CDC’s CORE (an
acronym for C-cultivate comprehensive
health equity science, O-optimize
interventions, R-reinforce and expand
robust partnerships, and E-enhance
capacity and workforce diversity and
inclusion) strategy around health equity.
The HEW membership will be
comprised of approximately 15
members. It will be chaired by two
current ACD, CDC Special Government
Employees. HEW co-chairs will present
their findings, observations, and work
products at one or more ACD, CDC
meetings for discussion, deliberation,
and decisions (final recommendations
to CDC).
Nomination Criteria: HEW members
will serve terms ranging from six
months to one year and be required to
attend HEW meetings approximately 1–
2 times per month (virtually or inperson), and contribute time in between
meetings for research, consultation,
discussion, and writing assignments.
Nominations are being sought for
individuals who have the expertise and
qualifications necessary to contribute to
the accomplishments of the
committee’s/workgroup’s objectives.
Nominees will be selected based on
expertise in the fields of health equity;
public health science and practice;
public health policy development,
analysis, and implementation. To
ensure a diverse workgroup
composition, nominees with front line
and field experience at the local, state,
tribal and territorial levels are
encouraged to apply. This includes
nominees with experience working for,
and with, community-based
organizations and other non-profit
organizations. Federal employees will
not be considered for membership.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of the HEW’s
objectives.
HHS policy stipulates that
membership be balanced in terms of
points of view represented and the
workgroup’s function. Appointments
shall be made without discrimination
based on age, race, ethnicity, gender,
sexual orientation, gender identity, HIV
status, disability, and cultural, religious,
or socioeconomic status. Nominees
must be U.S. citizens and cannot be fulltime employees of the U.S. Government.
Current participation on federal
workgroups or prior experience serving
on a federal advisory committee does
not disqualify a candidate; however,
HHS policy is to avoid excessive
VerDate Sep<11>2014
17:50 Mar 04, 2022
Jkt 256001
individual service on advisory
committees and multiple committee
memberships. Interested candidates
should submit the following items:
D A one-half to one-page cover letter
that includes your understanding of,
and commitment to, the time and work
necessary; one to two sentences on your
background and experience; and one to
two sentences on the skills/perspective
you would bring to the HEW.
D Current curriculum vitae which
highlights the experience and work
history being sought relevant to the
criteria set forth above, including
complete contact information
(telephone numbers, mailing address,
email address).
Nominations may be submitted by the
candidate him or herself, or by the
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
The meeting is being amended to
change the meeting date and should
read as follows:
CE22–003, Rigorously Evaluating
Programs and Policies to Prevent Child
Sexual Abuse (CSA): April 19, 2022.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for
Injury Prevention and Control, CDC,
4770 Buford Highway NE, Mailstop
S106–9, Atlanta, Georgia 30341,
Telephone (404) 639–6473, AWilkes@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–04681 Filed 3–4–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[FR Doc. 2022–04690 Filed 3–4–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE22–003,
Rigorously Evaluating Programs and
Policies To Prevent Child Sexual
Abuse (CSA); Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—CE22–
003, Rigorously Evaluating Programs
and Policies to Prevent Child Sexual
Abuse (CSA), April 19–20, 2022, 8:30
a.m., EDT–5:30 p.m., EDT, Web
Conference, in the original FRN. The
meeting was published in the Federal
Register on January 14, 2022, Volume
87, Number 10, page 2439.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—RFA–CE22–
002, Grants To Support New
Investigators in Conducting Research
Related To Preventing Interpersonal
Violence Impacting Children and
Youth; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—RFA–
CE22–002, Grants to Support New
Investigators in Conducting Research
Related to Preventing Interpersonal
Violence Impacting Children and Youth,
March 8–9, 2022, 8:30 a.m., EDT–5:30
p.m., EDT, Web Conference, in the
original FRN. The meeting was
published in the Federal Register on
January 5, 2022, Volume 87, Number 3,
page 460.
The meeting is being amended to
change the meeting date and should
read as follows:
RFA–CE22–002, Grants to Support
New Investigators in Conducting
Research Related to Preventing
E:\FR\FM\07MRN1.SGM
07MRN1
]]>Agencies
[Federal Register Volume 87, Number 44 (Monday, March 7, 2022)]
[Notices]
[Pages 12709-12710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04690]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to CDC's Advisory
Committee to the Director (ACD) Health Equity Workgroup (HEW)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), is seeking
nominations for membership on the Advisory Committee to the Director
(ACD) Health Equity Workgroup (HEW). The HEW will consist of
approximately 15 members who are experts in fields associated with
health equity; public health science and practice; public health policy
development, analysis, and implementation.
DATES: Nominations for membership on the HEW workgroup must be received
no later than March 17, 2022. Late nominations will not be considered
for membership.
ADDRESSES: All nominations (cover letters and curriculum vitae) should
be emailed to [email protected] with the subject line: ``Nomination
for CDC ACD HEW Workgroup.''
FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, MPA, Centers for
Disease Control and Prevention, Office of the Chief of Staff, 1600
Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027, Telephone:
(404) 639-7000; Email Address: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The purpose of the ACD, CDC is to advise the Secretary,
HHS, and the Director, CDC, on policy and broad strategies that will
enable CDC to fulfill its mission of protecting health through health
promotion, prevention, and preparedness. The ACD, CDC consists of up to
15 non-federal members, including the Chair, knowledgeable in areas
pertinent to the CDC mission, such as health policy, public health,
global health, preparedness, preventive medicine, the faith-based and
community-based sector, and allied fields.
[[Page 12710]]
Purpose: The establishment and formation of the HEW is to provide
input to the ACD, CDC on agency-wide activities related to the scope
and implementation of CDC's CORE (an acronym for C-cultivate
comprehensive health equity science, O-optimize interventions, R-
reinforce and expand robust partnerships, and E-enhance capacity and
workforce diversity and inclusion) strategy around health equity. The
HEW membership will be comprised of approximately 15 members. It will
be chaired by two current ACD, CDC Special Government Employees. HEW
co-chairs will present their findings, observations, and work products
at one or more ACD, CDC meetings for discussion, deliberation, and
decisions (final recommendations to CDC).
Nomination Criteria: HEW members will serve terms ranging from six
months to one year and be required to attend HEW meetings approximately
1-2 times per month (virtually or in-person), and contribute time in
between meetings for research, consultation, discussion, and writing
assignments.
Nominations are being sought for individuals who have the expertise
and qualifications necessary to contribute to the accomplishments of
the committee's/workgroup's objectives. Nominees will be selected based
on expertise in the fields of health equity; public health science and
practice; public health policy development, analysis, and
implementation. To ensure a diverse workgroup composition, nominees
with front line and field experience at the local, state, tribal and
territorial levels are encouraged to apply. This includes nominees with
experience working for, and with, community-based organizations and
other non-profit organizations. Federal employees will not be
considered for membership. Selection of members is based on candidates'
qualifications to contribute to the accomplishment of the HEW's
objectives.
HHS policy stipulates that membership be balanced in terms of
points of view represented and the workgroup's function. Appointments
shall be made without discrimination based on age, race, ethnicity,
gender, sexual orientation, gender identity, HIV status, disability,
and cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Interested
candidates should submit the following items:
[ssquf] A one-half to one-page cover letter that includes your
understanding of, and commitment to, the time and work necessary; one
to two sentences on your background and experience; and one to two
sentences on the skills/perspective you would bring to the HEW.
[ssquf] Current curriculum vitae which highlights the experience
and work history being sought relevant to the criteria set forth above,
including complete contact information (telephone numbers, mailing
address, email address).
Nominations may be submitted by the candidate him or herself, or by
the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-04690 Filed 3-4-22; 8:45 am]
BILLING CODE 4163-18-P
